ECM Therapeutics

About:

ECM Therapeutics is a regenerative medicine company that develops natural biomaterial to treat disease and injury.

Website: https://ecmtherapeutics.com/

Description:

ECM Therapeutics is a regenerative medicine company that develops natural biomaterial to treat disease and injury. The company also develops and manufactures diagnostic and therapeutic products derived from a naturally occurring material called extracellular matrix (ECM). It provides cues for cell attachment, migration, proliferation, and 3-D spatial organization. ECM Therapeutics'​ patented ECM hydrogel technology allows for expanded, less invasive applications in multiple disease areas. It utilizes the body’s own template to restore naturally occurring functional tissue following injury. ECM Therapeutics was founded in 2018 and is based in Warrendale, Pennsylvania, United States.

Total Funding Amount:

$37M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Warrendale, Pennsylvania, United States

Founded Date:

2018-01-01

Founders:

Katie Collins, Stephen Badylak

Number of Employees:

1-10

Last Funding Date:

2019-06-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai